Langdahl, B, Hofbauer, L C, Ferrari, S, Wang, Z, Fahrleitner-Pammer, A, Gielen, E, Lakatos, P, Czerwinski, E, Gimeno, E J, Timoshanko, J, Oates, M & Libanati, C 2022, ' Romosozumab efficacy and safety in European patients enrolled in the FRAME trial ', Osteoporosis International, vol. 33, no. 12, pp. 2527-2536 . https://doi.org/10.1007/s00198-022-06544-2
Miller, P D, Adachi, J D, Albergaria, B H, Cheung, A M, Chines, A A, Gielen, E, Langdahl, B L, Miyauchi, A, Oates, M, Reid, I R, Santiago, N R, Vanderkelen, M, Wang, Z & Yu, Z 2022, ' Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease ', Journal of Bone and Mineral Research, vol. 37, no. 8, pp. 1437-1445 . https://doi.org/10.1002/jbmr.4563
McClung, M R, Bolognese, M A, Brown, J P, Reginster, J Y, Langdahl, B L, Shi, Y, Timoshanko, J, Libanati, C, Chines, A & Oates, M K 2021, ' Skeletal responses to romosozumab after 12 months of denosumab ', JBMR Plus, vol. 5, no. 7, e10512 . https://doi.org/10.1002/jbm4.10512 JBMR Plus, Vol 5, Iss 7, Pp n/a-n/a (2021) JBMR Plus